Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shiratori

Showing results (131-140 of 215) with videos related to

Pageof 22
Sort By:
Gut|August 21, 2001
Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjectsY Yamaji, T Mitsushima, H Ikuma, et al.
The American Journal of Gastroenterology|November 1, 1985
Significance of a gastric mass screening surveyY Shiratori, S Nakagawa, A Kikuchi, et al.
Digestive Diseases and Sciences|March 22, 2001
High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load. IFN-beta Research GroupY Shiratori, R Nakata, N Shimizu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 16, 2002
Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosisH Tsugeno, H Tsugeno, T Fujita, et al.
Scandinavian Journal of Gastroenterology|June 11, 2003
A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal refluxH Tsugeno, M Mizuno, S Fujiki, et al.
Biochemical and Biophysical Research Communications|September 30, 1994
Modulation of KC/gro protein (interleukin-8 related protein in rodents) release from hepatocytes by biologically active mediatorsY Shiratori, Y Hikiba, E Mawet, et al.
Scandinavian Journal of Gastroenterology|February 15, 2002
Weak response of helicobacter pylori antibody is high risk for gastric cancer: a cross-sectional study of 10,234 endoscoped JapaneseY Yamaji, T Mitsushima, H Ikuma, et al.
Cancer|October 1, 1991
Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic studyS Shiina, K Tagawa, T Unuma, et al.
AJR. American Journal of Roentgenology|September 1, 1990
Percutaneous ethanol injection therapy for neoplasms located on the surface of the liverS Shiina, K Tagawa, T Unuma, et al.
AJR. American Journal of Roentgenology|May 1, 1993
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patientsS Shiina, K Tagawa, Y Niwa, et al.
Pageof 22

Showing results (131-140 of 215) with videos related to

Sort By:
Pageof 22
Gut|August 21, 2001
Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjectsY Yamaji, T Mitsushima, H Ikuma, et al.
The American Journal of Gastroenterology|November 1, 1985
Significance of a gastric mass screening surveyY Shiratori, S Nakagawa, A Kikuchi, et al.
Digestive Diseases and Sciences|March 22, 2001
High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load. IFN-beta Research GroupY Shiratori, R Nakata, N Shimizu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 16, 2002
Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosisH Tsugeno, H Tsugeno, T Fujita, et al.
Scandinavian Journal of Gastroenterology|June 11, 2003
A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal refluxH Tsugeno, M Mizuno, S Fujiki, et al.
Biochemical and Biophysical Research Communications|September 30, 1994
Modulation of KC/gro protein (interleukin-8 related protein in rodents) release from hepatocytes by biologically active mediatorsY Shiratori, Y Hikiba, E Mawet, et al.
Scandinavian Journal of Gastroenterology|February 15, 2002
Weak response of helicobacter pylori antibody is high risk for gastric cancer: a cross-sectional study of 10,234 endoscoped JapaneseY Yamaji, T Mitsushima, H Ikuma, et al.
Cancer|October 1, 1991
Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic studyS Shiina, K Tagawa, T Unuma, et al.
AJR. American Journal of Roentgenology|September 1, 1990
Percutaneous ethanol injection therapy for neoplasms located on the surface of the liverS Shiina, K Tagawa, T Unuma, et al.
AJR. American Journal of Roentgenology|May 1, 1993
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patientsS Shiina, K Tagawa, Y Niwa, et al.
Pageof 22